Phase I proof-of-mechanism trial of DV 1179 in patients with systemic lupus erythematosus.

Trial Profile

Phase I proof-of-mechanism trial of DV 1179 in patients with systemic lupus erythematosus.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 28 Nov 2014

At a glance

  • Drugs DV 1179 (Primary)
  • Indications Systemic lupus erythematosus
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 21 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top